C
IMVT icon

Covestor’s Immunovant IMVT Stock Holding History

Covestor’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97K Sell
2,529
-67
-3% -$2.04K 0.06% 375
2026
Q1 		$64K Buy
2,596
+145
+6% +$3.75K 0.04% 545
2025
Q4 		$63K Sell
2,451
-6,927
-74% -$154K 0.03% 818
2025
Q3 		$152K Buy
9,378
+7,941
+553% +$129K 0.08% 330
2025
Q2 		$23K Sell
1,437
-2,327
-62% -$35.2K 0.01% 1202
2025
Q1 		$64K Buy
3,764
+2,455
+188% +$51.4K 0.04% 737
2024
Q4 		$32K Sell
1,309
-1,515
-54% -$43K 0.02% 1012
2024
Q3 		$80K Buy
2,824
+317
+13% +$9.35K 0.05% 653
2024
Q2 		$66K Buy
2,507
+2,254
+891% +$64.1K 0.04% 727
2024
Q1 		$8K Sell
253
-1
-0.4% -$36 0.01% 1703
2023
Q4 		$11K Buy
254
+245
+2,722% +$9.02K 0.01% 1491
2023
Q3 		$0 Sell
9
-2
-18% -$45 ﹤0.01% 2371
2023
Q2 		$0 Hold
11
– – ﹤0.01% 2366
2023
Q1 		$0 Sell
11
-3
-21% -$52 ﹤0.01% 2280
2022
Q4 		$0 Buy
+14
New +$176 ﹤0.01% 2302

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Covestor's IMVT Position: Q2 2026 in Review

Covestor reduced its Immunovant (IMVT) stake by 2.6% in Q2 2026, selling an estimated $2.04K and leaving 2,529 shares worth $97K. The position accounts for 0.06% of the portfolio, ranked #375.

Covestor first reported a position in IMVT in Q4 2022 and has held it in 15 quarters since. The position peaked at $152K in Q3 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Covestor held 2,529 shares of Immunovant worth $97K as of Q2 2026.
  • Covestor sold 67 Immunovant shares in Q2 2026, an estimated $2.04K.
  • Immunovant made up 0.06% of Covestor's portfolio in Q2 2026, its #375 holding.
  • Covestor first reported a position in Immunovant in Q4 2022 and has held it in 15 quarters since.
  • Covestor's Immunovant position peaked at $152K in Q3 2025.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.